ACCENTIA BIOPHARMACEUTICALS INC (ABPI) [Rocket]

In millions, except per share items	Dec-31-12	Sep-30-12	Jun-30-12	Mar-31-12	Dec-31-11	Sep-30-11	Jun-30-11	Mar-31-11
	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q
Net income	-8,733.5	-4.3	3.1	-6.2	660.5	-11.6	-2.8	-1.1
Depreciation and amortization [+]	44.0	0.0	0.0	-128.8	129.0	0.2	0.1	0.1
Depreciation	41.8	0.0	0.0	0.1	33.1	0.0	0.0	0.0
Amortization of intangible assets	2.2	0.0	0.0	0.1	95.9	0.1	0.1	0.1
Stock-based compensation	88.8	0.1	0.1	-124.3	127.9	0.3	1.8	3.4
Change in working capital [+]	2,108.2	-4.0	1.5	-1,369.2	1,372.7	13.0	0.6	2.0
Accounts receivable	20.6	0.1	0.1	-92.8	93.6	-0.1	-0.5	0.4
Inventories	-1.9	0.1	0.0	67.0	-66.9	-0.1	0.0	0.0
Other current assets		0.0	0.0	-0.1			0.0	0.8
Accounts payable	141.7	0.2	-0.2	-269.9	270.3	0.0	-0.1	0.0
Accrued expenses			1.6	1.2			1.2	0.8
Deferred revenues			0.0	0.4
Other		-4.4	0.1	-1,075.0		13.3
Other operating activities	5,108.9	6.6	-6.8	2,973.2	-3,637.4	-3.6	-1.7	-5.6
Cash from operations	-1,383.6	-1.6	-2.0	1,344.6	-1,347.3	-1.7	-2.0	-1.2

Capital expenditures [+]	-4.6	0.2	-0.2	97.4	-97.5	-0.1	-0.5	-0.1
Purchases of property and equipment	-4.6	0.2	-0.2	97.4	-97.5	-0.1	-0.5	-0.1
Sales of property and equipment				5.5
Other cash from investing				-4,000.0
Cash from investing	-4.6	0.2	-0.2	-3,897.1	3,902.5	-0.1	-0.5	-0.1

Issuance of common stock, net		0.6	0.3	0.4
Option exercises			0.0	0.1
Financing costs						-1.1	0.1
Other cash from financing	1,712.6	376.4	0.5	2,677.3	-2,678.7	-5,944.2	1.5	0.0
Cash from financing	1,712.6	377.1	0.7	2,677.5	-2,678.7	-5,943.2	1.3	0.0

Free cash flow	-1,388.2	-1.3	-2.2	1,441.9	-1,444.8	-1.8	-2.5	-1.2
Per share (diluted)	($1,172,749.40)	($0.02)	($0.02)	$18.41		($0.03)	($0.04)	($0.02)

Cash paid for interest			0.0	0.1			0.1